SCHEMBL2783149

SCHEMBL2783149

O=C(c1ccccc1)c1c(Br)sc2c1ccc(=O)n2-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
HPGD P15428 2/20 0.40
THRB P10828 1/20 0.40
HTT P42858 1/20 0.39
GSK3A P49840 3/20 0.38
GSK3B P49841 3/20 0.38
PTK2B Q14289 1/20 0.36
MAPK14 Q16539 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GRM6 O15303 1/20 0.33
LMNA P02545 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33
CYP1A2 P05177 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2781105 0.91 LMNA (0.38) ALDH1A1KMT2AMEN1HPGDTHRB
SCHEMBL2781961 0.91 MAPK14 (0.39) ALDH1A1KMT2AMEN1HPGDTHRB
SCHEMBL2782491 0.88 POLB (0.40) ALDH1A1HPGDHTTNPSR1LMNA
SCHEMBL2782016 0.85 MAPK8 (0.42) ALDH1A1KMT2AMEN1HPGDHTT
SCHEMBL2784096 0.84 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1HPGDTHRB
SCHEMBL2780524 0.84 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1HPGDTHRB
SCHEMBL2784939 0.84 MAPK13 (0.38) ALDH1A1KMT2AMEN1MAPK14L3MBTL1
SCHEMBL2781235 0.83 PTGFR (0.38) ALDH1A1KMT2ATHRBNPSR1CYP2C9
SCHEMBL2779886 0.83 MAPK8 (0.40) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL2780284 0.82 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1HPGDTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795256-B2 Thieno-pyridinone derivatives as kinase inhibitors UCB PHARMA S.A. (BE) 2010-09-14 US disclosed
US-20070078131-A1 Thieno-pyridinone derivatives as kinase inhibitors CELLTECH R&D LIMITED (GB) 2007-04-05 US disclosed
EP-1680429-A1 THIENO-PYRIDINONE DERIVATIVES AS KINASE INHIBITORS Celltech R & D Limited (GB) 2006-07-19 EP disclosed
WO-2005042540-A1 THIENO-PYRIDINONE DERIVATIVES AS KINASE INHIBITORS CELLTECH R & D LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078131-A1 Thieno-pyridinone derivatives as kinase inhibitors MAP3K6, MAP4K2, MAP3K15 ALDH1A1 2586/4885KMT2A 2311/4885MEN1 4446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.